Dr. Cascone on Combination Checkpoint Blockade for Early-Stage Non–Small-Cell Lung Cancer

June 7, 2019
Tina Cascone, MD, PhD

Cancer Network spoke with Tina Cascone, MD, of MD Anderson Cancer Center, at ASCO 2019 about combination checkpoint blockade in the pre-surgical setting for early-stage NSCLC.

Cancer Network spoke with Tina Cascone, MD, an oncologist and assistant professor of Thoracic/Head & Neck Medical Oncology at MD Anderson Cancer Center, about the combination checkpoint blockade effective in the pre-surgical setting for early-stage non–small-cell lung cancer. The results of the study (abstract 8504) were presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Related Content:

ASCO Lung Cancer | Lung Cancer